Skip to Content

Pharmaceutics, Volume 4, Issue 1

2012 March - 15 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

  • Review
  • Open Access
32 Citations
8,271 Views
9 Pages

Ophthalmic Drug Delivery in Glaucoma—A Review

  • Ingrida Januleviciene,
  • Lina Siaudvytyte and
  • Ruta Barsauskaite

Glaucoma is a progressive optic neuropathy and medical therapy is the initial option for the treatment of this potentially blinding condition. Topical instillation of eye drops from the bottle is the most common glaucoma drug delivery form. Due to li...

(This article belongs to the Special Issue Ocular Drug Delivery)
  • Review
  • Open Access
5 Citations
11,868 Views
13 Pages

Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema

  • Aaron Pickrell,
  • Alon Harris,
  • Sandra Ngo,
  • Annahita Amireskandari,
  • Erin Stewart and
  • Brent Siesky

Macular edema (ME) is one of the eventual outcomes of various intraocular and systemic pathologies. The pathogenesis for ME is not yet entirely understood; however, some of the common risk factors for its development have been identified. While this...

(This article belongs to the Special Issue Ocular Drug Delivery)
  • Article
  • Open Access
2 Citations
8,074 Views
18 Pages

Evaluation of Tissue Interactions with Mechanical Elements of a Transscleral Drug Delivery Device

  • Sarah J. Cohen,
  • Robison V. Paul Chan,
  • Mark Keegan,
  • Christopher M. Andreoli,
  • Jeffrey T. Borenstein,
  • Joan W. Miller and
  • Evangelos S. Gragoudas

The goal of this work was to evaluate tissue-device interactions due to implantation of a mechanically operated drug delivery system onto the posterior sclera. Two test devices were designed and fabricated to model elements of the drug delivery devic...

(This article belongs to the Special Issue Ocular Drug Delivery)
  • Review
  • Open Access
62 Citations
11,029 Views
15 Pages

Ocular Drug Delivery for Glaucoma Management

  • Nathan Gooch,
  • Sarah A. Molokhia,
  • Russell Condie,
  • Randon Michael Burr,
  • Bonnie Archer,
  • Balamurali K. Ambati and
  • Barbara Wirostko

Current glaucoma management modalities are hindered by low patient compliance and adherence. This can be due to highly complex treatment strategies or poor patient understanding. Treatments focus on the management or reduction of intraocular pressure...

(This article belongs to the Special Issue Ocular Drug Delivery)
  • Article
  • Open Access
39 Citations
10,487 Views
18 Pages

Preparation and Characterization of Amino Acids-Based Trimethoprim Salts

  • Amr ElShaer,
  • Peter Hanson,
  • Tony Worthington,
  • Peter Lambert and
  • Afzal R. Mohammed

16 February 2012

Trimethoprim (TMP) is a dihydrofolate reductase (DHFR) inhibitor which prevents the conversion of dihydrofolic acid into tetrahydrofolic acid, resulting in the depletion of the latter and leading to bacterial death. Oral bioavailability of TMP is hin...

  • Article
  • Open Access
11 Citations
11,568 Views
15 Pages

9 February 2012

The objective of this work was to study the polymorphic transformation of carbamazepine from Form II to Form III in 1-propanol during seeded isothermal batch crystallization. First, the pure Form II and Form III were obtained and characterized. Then...

  • Article
  • Open Access
212 Citations
21,588 Views
15 Pages

6 February 2012

Probiotic encapsulation technology (PET) has the potential to protect microorgansisms and to deliver them into the gut. Because of the promising preclinical and clinical results, probiotics have been incorporated into a range of products. However, th...

(This article belongs to the Special Issue Microencapsulation Technology Applied to Pharmaceutics)
  • Review
  • Open Access
37 Citations
9,163 Views
19 Pages

1 February 2012

Gene, short hairpin RNA (shRNA) and small interfering RNA (siRNA) delivery can be particularly used for the treatment of diseases by the entry of genetic materials mammalian cells either to express new proteins or to suppress the expression of protei...

(This article belongs to the Special Issue Gene Therapy)
  • Article
  • Open Access
22 Citations
8,752 Views
11 Pages

Atomic Pairwise Distribution Function Analysis of the Amorphous Phase Prepared by Different Manufacturing Routes

  • Johan P. Boetker,
  • Vishal Koradia,
  • Thomas Rades,
  • Jukka Rantanen and
  • Marja Savolainen

Amlodipine besilate, a calcium channel antagonist, exists in several solid forms. Processing of anhydrate and dihydrate forms of this drug may lead to solid state changes, and is therefore the focus of this study. Milling was performed for the anhydr...

  • Article
  • Open Access
36 Citations
13,870 Views
26 Pages

31 January 2012

This article introduces the formulation of alcohol-free, lecithin microemulsion-based gels (MBGs) prepared with gelatin as gelling agent. The influence of oil, water, lecithin and hydrophilic and lipophilic additives (linkers) on the rheological prop...

(This article belongs to the Special Issue Transdermal Drug Delivery)
  • Review
  • Open Access
39 Citations
12,110 Views
22 Pages

The stratum corneum is a major barrier of drug penetration across the skin in transdermal delivery. For effective transdermal drug delivery, skin penetration enhancers are used to overcome this barrier. In the past decades, a number of research studi...

(This article belongs to the Special Issue Transdermal Drug Delivery)
  • Article
  • Open Access
8 Citations
11,298 Views
13 Pages

Physical properties of commercial carbamazepine (CBZ) samples can significantly influence drug release and thereby jeopardize bioequivalence of the final dosage form. The aim of this study was to reduce variability in commercial CBZ samples by recrys...

  • Review
  • Open Access
12 Citations
8,884 Views
16 Pages

Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles

  • Satoko Kishimoto,
  • Masayuki Ishihara,
  • Megumi Takikawa,
  • Yasutaka Mori,
  • Hidemi Hattori,
  • Masanori Fujita and
  • Shingo Nakamura

Low-molecular-weight heparin/protamine microparticles (LMW-H/P MPs) were produced as a carrier for heparin-binding growth factors (GFs) and for various adhesive cells. A mixture of low-molecular-weight heparin (MW: approximately 5000 Da, 6.4 mg/mL) a...

(This article belongs to the Special Issue Microencapsulation Technology Applied to Pharmaceutics)
  • Review
  • Open Access
57 Citations
12,406 Views
25 Pages

Trojan Microparticles for Drug Delivery

  • Nicolas Anton,
  • Anshuman Jakhmola and
  • Thierry F. Vandamme

During the last decade, the US Food and Drug Administration (FDA) have regulated a wide range of products, (foods, cosmetics, drugs, devices, veterinary, and tobacco) which may utilize micro and nanotechnology or contain nanomaterials. Nanotechnology...

(This article belongs to the Special Issue Microencapsulation Technology Applied to Pharmaceutics)
  • Review
  • Open Access
150 Citations
16,277 Views
16 Pages

Tissue Engineered Human Skin Equivalents

  • Zheng Zhang and
  • Bozena B. Michniak-Kohn

Human skin not only serves as an important barrier against the penetration of exogenous substances into the body, but also provides a potential avenue for the transport of functional active drugs/reagents/ingredients into the skin (topical delivery)...

(This article belongs to the Special Issue Transdermal Drug Delivery)
XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923